Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 21, 2026
TickeronGET DAILY SIGNALS
Northpointe Bancshares Q2 2026 Earnings Preview: What the Numbers May Reveal

Northpointe Bancshares Q2 2026 Earnings Preview: What the Numbers May Reveal

Key Takeaways

  • Northpointe Bancshares, Inc. is scheduled to release second quarter 2026 financial results on July 21, 2026.
  • Analysts project earnings per share of $0.68 for the quarter.
  • Investors will monitor net interest income trends and loan growth amid banking sector conditions.
  • The earnings call is set for July 22, 2026, at 10:00 a.m. EDT.
  • Recent first quarter performance provides a baseline for expected sequential changes.

Why This Report Matters Now

Northpointe Bancshares, Inc. operates as the holding company for Northpointe Bank, serving customers primarily in Michigan and surrounding regions. The second quarter 2026 report will offer fresh insight into the bank’s performance following its first quarter results released in April. With interest rate environments and regional economic factors influencing banking operations, this update helps investors assess revenue stability, credit quality, and overall profitability trends in a competitive sector.

Earnings Forecasts and Benchmarks

Consensus estimates point to earnings per share of $0.68 for the second quarter ended June 30, 2026. This figure serves as a benchmark for the upcoming release. Investors typically watch revenue growth, net interest margin, and any updates on loan origination or deposit trends. Historical reactions to prior quarterly reports have influenced short-term stock movement, with attention often centered on whether results align with or diverge from analyst projections. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Sentiment Ahead of the Release

Sentiment ahead of the report reflects typical pre-earnings caution in the regional banking space. Market participants are assessing broader sector performance and any signals of economic resilience. Key risk factors include potential volatility tied to interest rate expectations and regional lending conditions, which could shape immediate stock response once results are available.

Using AI Tools in My Research Process

When preparing for earnings seasons like this one, I find it helpful to run quick scans across the banking sector. Tickeron’s AI Screener allows me to filter for similar institutions based on fundamentals, recent performance, and technical patterns. It has become a regular part of how I cross-check expectations and identify where Northpointe Bancshares, Inc. stands relative to peers. The tool supports customizable searches by industry, market cap, and key metrics, which can surface ideas worth monitoring around report dates.

Forward Outlook and Factors to Watch

Following the second quarter release, investors should focus on management commentary regarding third quarter trends and any provided guidance. Loan demand, deposit costs, and credit metrics will likely feature prominently in discussions.

Broader industry dynamics, such as regulatory developments or shifts in consumer spending, may also influence the bank’s trajectory. Monitoring these elements will help clarify the sustainability of recent performance patterns.

Upcoming catalysts include the earnings conference call and any subsequent updates on capital allocation or expansion plans. Cost management and margin pressures remain areas of ongoing interest for stakeholders tracking the company’s progress.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NPB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


NPB in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 28, 2026

NPB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 8 similar instances where the stock broke above the upper band. In 7 of the 8 cases the stock fell afterwards. This puts the odds of success at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 16 of 22 cases where NPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

NPB moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for NPB entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NPB's RSI Indicator exited the oversold zone, 3 of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 38%.

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on NPB as a result. In 22 of 33 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for NPB just turned positive on October 07, 2026. Looking at past instances where NPB's MACD turned positive, the stock continued to rise in 11 of 13 cases over the following month. The odds of a continued upward trend are 85%.

Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where NPB advanced for three days, in 58 of 94 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.891) is normal, around the industry mean (1.263). P/E Ratio (6.706) is within average values for comparable stocks, (13.498). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.190). Dividend Yield (0.008) settles around the average of (0.035) among similar stocks. P/S Ratio (2.276) is also within normal values, averaging (3.738).

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. NPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.

Notable companies

The most notable companies in this group are US Bancorp (NYSE:USB), PNC Financial Services Group (NYSE:PNC), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.02B. The market cap for tickers in the group ranges from 147.87 to 173.74B. DBSDF holds the highest valuation in this group at 173.74B. The lowest valued company is VLYPP at 147.87.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 7%. FGBI experienced the highest price growth at 22%, while SHFS experienced the biggest fall at -58%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 53
Price Growth Rating: 48
SMR Rating: 37
Profit Risk Rating: 55
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry RegionalBanks

Industry
N/A
Address
3333 Deposit Drive Northeast
Phone
+1 616 940-9400
Employees
491
Web
https://www.northpointe.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.